Skip to main content
Breast Cancer Research : BCR logoLink to Breast Cancer Research : BCR
. 2021 Mar 15;23:32. doi: 10.1186/s13058-021-01414-x

Correction to: Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent

Zoltan Szucs 1, James Joseph 1,2,3, Tim J Larkin 1, Bangwen Xie 1, Sarah E Bohndiek 1,2, Kevin M Brindle 1,4,, André A Neves 1,
PMCID: PMC7958420  PMID: 33722249

Correction to: Breast Cancer Res (2021) 23:25

https://doi.org/10.1186/s13058-021-01404-z

After publication of the original article [1], the authors identified two errors in Figure 6.

The correct figure is given below.

graphic file with name 13058_2021_1414_Figa_HTML.jpg

The original article has been corrected.

Contributor Information

Kevin M. Brindle, Email: kmb1001@cam.ac.uk

André A. Neves, Email: andre.neves@cruk.cam.ac.uk

Reference

  • 1.Szucs Z, et al. Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent. Breast Cancer Res. 2021;23:25. doi: 10.1186/s13058-021-01404-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Breast Cancer Research : BCR are provided here courtesy of BMC

RESOURCES